Kiran Mazumdar-Shaw
Director · Bicara Therapeutics Inc.
Individual
- 2026
- Jun 10, 2026
- 1
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Kiran Mazumdar-Shaw files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- RA CAPITAL MANAGEMENT, L.P. - $40.00M in BCAX purchases and sales in the last 12 months
- Claire Mazumdar - $3.59M in BCAX purchases and sales in the last 12 months
- Ryan Cohlhepp - $3.46M in BCAX purchases and sales in the last 12 months
- Ivan Hyep - $2.40M in BCAX purchases and sales in the last 12 months
- David Raben - $741K in BCAX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Kiran Mazumdar-Shaw?
Kiran Mazumdar-Shaw is a corporate insider, tracked as Director of Bicara Therapeutics Inc. (BCAX). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Kiran Mazumdar-Shaw last file a Form 4?
The only primary Form 4 on record is dated 10 June 2026.